Viewing Study NCT01714193


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-06-11 @ 2:33 PM
Study NCT ID: NCT01714193
Status: COMPLETED
Last Update Posted: 2012-11-19
First Post: 2012-10-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy View
None Canagliflozin (JNJ-28431754) View
None Pharmacokinetics View
None Contraceptives, Oral View
None Ethinyl Estradiol View
None Levonorgestrel View
None LEVORA View